MRI-proton density fat fraction accurately reflects hepatic steatosis despite concomitant inflammation and fibrosis in a MASLD rat model
Abdominal Radiology · 2026
DOI: 10.1007/s00261-026-05566-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, 2026. Verfasst von Yuxi Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Liver Cirrhosis, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taizhou Science and Technology Bureau, Taizhou Science and Technology Program Projec.
Abstract (Originalsprache)
BACKGROUND: Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is a noninvasive biomarker for hepatic steatosis, but its quantitative reliability in the presence of inflammation or fibrosis remains incompletely defined. METHODS: Forty rats were fed a methionine-and choline-deficient (MCD) diet for 2, 4, 6, 8, or 10 weeks (n = 8 per time point), while eight additional rats served as controls. All animals underwent MRI-PDFF examination immediately prior to sacrifice, followed by histopathologic assessment within 4 h using the NASH Clinical Research Network scoring system. Associations between PDFF and histologic fat content, steatosis grade, inflammation, and fibrosis were analyzed using Pearson and Spearman correlations, with subgroup analyses performed in animals with fibrosis. RESULTS: MRI-PDFF showed a near-perfect correlation with histologic fat percentage in the entire cohort (r = 0.994, p 0.05). Intra-scan reproducibility of PDFF was excellent (intraclass correlation coefficient (ICC) = 0.935). CONCLUSIONS: MRI-PDFF provides a robust and reproducible quantitative assessment of hepatic steatosis in the MCD rat model of MASLD. Its quantitative relationship with hepatic fat burden and steatosis grade is preserved in animals with concomitant fibrosis and is not materially influenced by inflammatory activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, China.
- Department of Radiology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, China.
- School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.
- Department of Pathology, First Affiliated Hospital Zhejiang University, Hangzhou, China.
- School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, China. zju_zhaofeng@zju.edu.cn.
- Department of Radiation Oncology, First Affiliated Hospital Zhejiang University, Hangzhou, China. zju_zhaofeng@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Taizhou Science and Technology Bureau, Taizhou Science and Technology Program Projec
Zitieren
APA
Ding, Y., Pang, J., Li, R., Wang, J., & Zhao, F. (2026). MRI-proton density fat fraction accurately reflects hepatic steatosis despite concomitant inflammation and fibrosis in a MASLD rat model. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05566-2
Vancouver
Ding Y, Pang J, Li R, Wang J, Zhao F. MRI-proton density fat fraction accurately reflects hepatic steatosis despite concomitant inflammation and fibrosis in a MASLD rat model. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05566-2
BibTeX
@article{Ding2026,
author = {Ding, Yuxi and Pang, Jianxin and Li, Ruoxi and Wang, Jili and Zhao, Feng},
title = {MRI-proton density fat fraction accurately reflects hepatic steatosis despite concomitant inflammation and fibrosis in a MASLD rat model},
journal = {Abdominal Radiology},
year = {2026},
doi = {10.1007/s00261-026-05566-2}
}
EUVIMED